Method of inhibiting HIV-1 viral rebound in a subject using interferon inhibitors and ART
US12024558B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 24, 2020 |
| Grant date | Jul 2, 2024 |
| Priority date | — |
| Expiry date | Apr 24, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16011
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating acquired immune deficiency syndrome (AIDS) in a subject in need thereof. In particular, the method includes the administration of a combination, a kit-of-parts, a composition or a pharmaceutical composition including an interferon-alpha (IFN-α) blocking agent, a type III interferon blocking agent, an antiretroviral (ART) agent and, optionally, an interferon-beta (IFN-β) blocking agent and/or a latency-reversing agent (LRA).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.